Clinical Trial Update: SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trial update for inhaled AR-501 in healthy adults and Pseudomonas aeruginosa-infected cystic fibrosis subjects; current status unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• AR-501

Snippet

Sponsor: Aridis Pharmaceuticals, Inc. | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: UNKNOWN